Pituitary Hormones < Pituitary Neoplasms < Placebos

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
000F14 (2012)		Hyperprolactinemia-related ¹³¹I uptake in nonlactating breasts.
002A44 (2006)		Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma.
002B44 (????)		[Incidental diagnosis of lymph node tuberculosis in an 111-indium-octreotide scintigraphy during a study of acromegaly].
002B89 (2005)		Neuroendocrine tumors and somatostatin: imaging techniques.
002F89 (2005)		Somatostatin analogs as radiodiagnostic tools.
003009 (2005)		The role of somatostatin receptor scintigraphy in patients with pituitary adenoma or post-surgical recurrent tumours.
003795 (2002)		The role of somatostatin receptor scintigraphy in the management of pituitary tumours.
003847 (2001)		[Somatostatin analogs in the clinical management of pituitary neoplasms].
003A40 (2001)		In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy.
003A61 (2001)		[What is your diagnosis? (Atypical) bronchial carcinoid, Cushing syndrome due to ectopic ACTH production (somatostatin receptor positive tumor). Incidentaloma of the hypophysis].
003D22 (2000)		[Diagnostic imaging of a TSH-producing pituitary adenoma associated with the "empty sella" by somatostatin and dopamine D2 receptor scintigraphy].
003D71 (1999)		Receptor imaging in the diagnosis and treatment of pituitary tumors.
003E21 (1999)		Receptor imaging with 111In-pentreotide and 123I-methoxybenzamide, and inhibition tests with octreotide and bromocriptine of mixed growth hormone/prolactin-secreting pituitary tumors.
003E27 (1999)		Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo.
003E92 (1999)		[Hyperthyroidism caused by a TSH producing pituitary adenoma].
003E99 (1999)		Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
003F02 (1999)		The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas.
003F26 (1999)		Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.
003F84 (1998)		Pituitary adenomas: the role of 111In-DTPA-octreotide SPET in the detection of minimal post-surgical residues.
004031 (1998)		Scintigraphic imaging of pituitary adenomas: an in vivo evaluation of somatostatin receptors.
004202 (1998)		Comparison of (111)In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Pituitary Neoplasms" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Pituitary Neoplasms" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Pituitary Neoplasms
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024